Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older
Clinical trial NCT05553301 · COMPLETED
Trial details
- NCT number
- NCT05553301
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2024-01-19
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.